Eli Lilly, Novo Nordisk Shares Dip as Pfizer Ramps Up Diabetes Drug Competition

Shares of $Eli Lilly and Co(LLY.US)$ and $Novo-Nordisk A/S(NVO.US)$ finished lower on Thursday, perhaps influenced by competitive developments and regulatory updates in the pharmaceutical sector.

Benzinga16:12 ET

This Weight Loss Stock Is the Best Alternative to Eli Lilly, Novo - SA Sentiment

Seeking Alpha22minutes ago

Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$197.36 Million in Common Stock

$Eli Lilly and Co(LLY.US)$ 10% Shareholder LILLY ENDOWMENT INC sold 210K shares of common stock on Jul 10, 2024 at an average price of $939.816 for a total value of $197.36 million.Source:

Moomoo News16:39 ET

Bernie Sanders Targets High Prices of Ozempic and Wegovy In US

Senator Bernie Sanders expressed confidence that Novo Nordisk A/S (NYSE:NVO) can be persuaded to reduce the U.S. prices of its popular weight-loss drugs, Ozempic and Wegovy, by publicly highlighting the disparity between domestic and international pricing.

Benzinga13:47 ET

Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by Berenberg

Eli Lilly Price Target Raised to $1000.00/Share From $850.00 by

Dow Jones12:52 ET

Berenberg Maintains Buy on Eli Lilly and Co, Raises Price Target to $1000

Berenberg analyst Kerry Holford maintains Eli Lilly and Co (NYSE:LLY) with a Buy and raises the price target from $850 to $1000.

Benzinga12:42 ET